-
The benefits and risks of testosterone replacement therapy: a review.
Bassil N, Alkaade S, Morley JE.
Ther Clin Risk Manag. 2009 Jun; 5(3):427-48. Epub 2009 Jun 22.
[Ther Clin Risk Manag. 2009]
-
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.
Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, et al.
Eur J Endocrinol. 2008 Nov; 159(5):507-14.
[Eur J Endocrinol. 2008]
-
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.
Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, et al.
Ann Intern Med. 2008 Oct 7; 149(7):461-71, W83-8.
[Ann Intern Med. 2008]